Search Results - "Johnson, Fraser D."

  • Showing 1 - 8 results of 8
Refine Results
  1. 1
  2. 2

    Extracellular signal-regulated kinase mediates chromatin rewiring and lineage transformation in lung cancer by Inoue, Yusuke, Nikolic, Ana, Farnsworth, Dylan, Shi, Rocky, Johnson, Fraser D, Liu, Alvin, Ladanyi, Marc, Somwar, Romel, Gallo, Marco, Lockwood, William W

    Published in eLife (14-06-2021)
    “…Lineage transformation between lung cancer subtypes is a poorly understood phenomenon associated with resistance to treatment and poor patient outcomes. Here,…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Characterizing the secretome of EGFR mutant lung adenocarcinoma by Luu, Jennifer K, Johnson, Fraser D, Jajarmi, Jana, Sihota, Tianna, Shi, Rocky, Lu, Daniel, Farnsworth, Dylan, Spencer, Sandra E, Negri, Gian Luca, Morin, Gregg B, Lockwood, William W

    Published in Frontiers in oncology (08-01-2024)
    “…Lung cancer is the leading cause of cancer related death worldwide, mainly due to the late stage of disease at the time of diagnosis. Non-invasive biomarkers…”
    Get full text
    Journal Article
  5. 5

    Tandem mass tag-based thermal proteome profiling for the discovery of drug-protein interactions in cancer cells by Johnson, Fraser D., Hughes, Christopher S., Liu, Alvin, Lockwood, William W., Morin, Gregg B.

    Published in STAR protocols (17-03-2023)
    “…Identification of effector targets is imperative to the characterization of the mechanisms of action of novel small molecules. Here, we describe steps to…”
    Get full text
    Journal Article
  6. 6

    MEK inhibitor resistance in lung adenocarcinoma is associated with addiction to sustained ERK suppression by Farnsworth, Dylan A., Inoue, Yusuke, Johnson, Fraser D., de Rappard-Yuswack, Georgia, Lu, Daniel, Shi, Rocky, Ma, Lok In Josephine, Mattar, Marissa S., Somwar, Romel, Ladanyi, Marc, Unni, Arun M., Lockwood, William W.

    Published in NPJ precision oncology (23-11-2022)
    “…MEK inhibitors (MEKi) have limited efficacy in KRAS mutant lung adenocarcinoma (LUAD) patients, and this is attributed to both intrinsic and adaptive…”
    Get full text
    Journal Article
  7. 7
  8. 8